Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Ultragenyx Pharmaceutical (RARE) Tax Rate (2017 - 2025)

Ultragenyx Pharmaceutical has reported Tax Rate over the past 9 years, most recently at 0.68% for Q4 2025.

  • Quarterly Tax Rate rose 36.0% to 0.68% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.7% through Dec 2025, down 17.0% year-over-year, with the annual reading at 0.7% for FY2025, 17.0% down from the prior year.
  • Tax Rate was 0.68% for Q4 2025 at Ultragenyx Pharmaceutical, down from 0.49% in the prior quarter.
  • Over five years, Tax Rate peaked at 0.01% in Q4 2021 and troughed at 2.63% in Q3 2022.
  • The 5-year median for Tax Rate is 0.39% (2021), against an average of 0.56%.
  • Year-over-year, Tax Rate tumbled -238bps in 2022 and then skyrocketed 222bps in 2023.
  • A 5-year view of Tax Rate shows it stood at 0.01% in 2021, then plummeted by -2152bps to 0.12% in 2022, then plummeted by -553bps to 0.81% in 2023, then decreased by -29bps to 1.04% in 2024, then soared by 35bps to 0.68% in 2025.
  • Per Business Quant, the three most recent readings for RARE's Tax Rate are 0.68% (Q4 2025), 0.49% (Q3 2025), and 0.83% (Q2 2025).